COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 84 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,207,000 | -11.1% | 79,728 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $1,357,000 | -40.3% | 79,052 | -48.7% | 0.00% | 0.0% |
Q3 2018 | $2,272,000 | +13.1% | 154,076 | +82.9% | 0.00% | 0.0% |
Q2 2018 | $2,009,000 | +31.5% | 84,249 | +40.8% | 0.00% | 0.0% |
Q1 2018 | $1,528,000 | +39.3% | 59,820 | +0.6% | 0.00% | 0.0% |
Q4 2017 | $1,097,000 | +76.7% | 59,443 | +0.5% | 0.00% | – |
Q3 2017 | $621,000 | -18.8% | 59,162 | -3.3% | 0.00% | -100.0% |
Q2 2017 | $765,000 | +78.7% | 61,187 | +44.0% | 0.00% | – |
Q1 2017 | $428,000 | -37.5% | 42,496 | -3.4% | 0.00% | -100.0% |
Q4 2016 | $685,000 | -16.9% | 43,995 | +2.9% | 0.00% | 0.0% |
Q3 2016 | $824,000 | +62.5% | 42,761 | 0.0% | 0.00% | – |
Q2 2016 | $507,000 | +19.0% | 42,761 | +82.1% | 0.00% | – |
Q1 2016 | $426,000 | -45.2% | 23,486 | -16.9% | 0.00% | -100.0% |
Q4 2015 | $777,000 | +36.3% | 28,260 | +9.7% | 0.00% | – |
Q3 2015 | $570,000 | +345.3% | 25,762 | +258.2% | 0.00% | – |
Q2 2015 | $128,000 | – | 7,193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,887,332 | $32,405,000 | 8.36% |
SECTORAL ASSET MANAGEMENT INC | 1,156,934 | $19,865,000 | 2.70% |
1492 Capital Management LLC | 150,189 | $2,579,000 | 2.31% |
Eventide Asset Management | 2,207,610 | $37,905,000 | 1.68% |
J. Goldman & Co LP | 1,066,847 | $18,318,000 | 1.41% |
HAMILTON LANE ADVISORS LLC | 89,975 | $1,545,000 | 1.35% |
Rock Springs Capital Management LP | 1,605,105 | $27,560,000 | 1.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 932,126 | $16,005,000 | 0.58% |
Opaleye Management Inc. | 80,000 | $1,373,000 | 0.51% |
Cortina Asset Management, LLC | 456,036 | $7,830,000 | 0.48% |